| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/13/2009 | US20090202616 Composite, Method of Producing the Composite and Uses of the Same |
| 08/13/2009 | US20090202595 Anti-pdef antibodies and uses thereof |
| 08/13/2009 | US20090202594 Anti-bacterial Vaccine Compositions |
| 08/13/2009 | US20090202593 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/13/2009 | US20090202589 Fermenter system for biotechnical processes |
| 08/13/2009 | US20090202588 Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences |
| 08/13/2009 | US20090202577 CASB618 Polynucleotides and Polypeptides and Their Use |
| 08/13/2009 | US20090202576 Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides |
| 08/13/2009 | US20090202573 Polymeric conjugates containing positively-charged moieties |
| 08/13/2009 | US20090202569 Prophylactic/Therapeutic Agent for Cancer |
| 08/13/2009 | US20090202568 Binding members for interleukin-4 receptor alpha (IL-4Ra)-173 |
| 08/13/2009 | US20090202566 Use of the ENDO-180 gene and polypeptide for diagnosis and treatment |
| 08/13/2009 | US20090202564 Methods of isolating stem cells |
| 08/13/2009 | US20090202563 C20ORF23 as modifier of the IGFR pathway and methods of use |
| 08/13/2009 | US20090202562 Anti-gfralpha3 antibodies |
| 08/13/2009 | US20090202561 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 08/13/2009 | US20090202559 conjugated drug for drug targeting at pancreatic cancer cell; biodrugs as antitumor agent, anticarcinogenic agent; free of side effect |
| 08/13/2009 | US20090202558 TNFalpha-NEUTRALIZING ANTIBODIES |
| 08/13/2009 | US20090202556 Anti-claudin-4 antibody |
| 08/13/2009 | US20090202554 Method of modulation of interaction between receptor and ligand |
| 08/13/2009 | US20090202553 Antibodies against anthrax protective antigen |
| 08/13/2009 | US20090202552 Gene expressed in prostate cancer and methods of use |
| 08/13/2009 | US20090202550 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor |
| 08/13/2009 | US20090202549 Anti-IL-12 Antibodies, Epitopes, Compositions, Methods and Uses |
| 08/13/2009 | US20090202548 Antibodies and related molecules that bind to psca proteins |
| 08/13/2009 | US20090202547 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 08/13/2009 | US20090202543 Gene and polypeptide relating to breast cancer |
| 08/13/2009 | US20090202532 High Functional Bispecific Antibody |
| 08/13/2009 | US20090202530 Identification of Tumor-Associated Antigens for Diagnosis and Therapy |
| 08/13/2009 | US20090202526 Agonist anti-trkc antibodies and methods using same |
| 08/13/2009 | US20090202511 Targeted protein replacement for the treatment of lysosomal storage disorders |
| 08/13/2009 | US20090202508 Negative regulation of hypoxia inducible factor 1 by os-9 |
| 08/13/2009 | US20090202506 loading antigen presenting cells from a subject; loading antigen presenting cells (APC's) having Class I MHC (major histocompatibility factor) molecules with T cell epitopes; culturing CD8+ T cells with APC's; expanding in culture; for allergic asthma |
| 08/13/2009 | US20090202504 Methods for the detection and prognosis of breast tumors |
| 08/13/2009 | US20090202503 Sequence of nucleotides and peptides gse 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof |
| 08/13/2009 | US20090202502 Hepatic stellate cell specific promoter and uses thereof |
| 08/13/2009 | US20090202501 Chimeric NK receptor and methods for treating cancer |
| 08/13/2009 | US20090202500 Pharmaceuticals That Promote Functional Regeneration of Damaged Tissues |
| 08/13/2009 | US20090202499 Human Telomerase Reverse Transcriptase Peptides |
| 08/13/2009 | US20090202498 Direct differentiation of cardiomyocytes from human embryonic stem cells |
| 08/13/2009 | US20090202496 Method for regenerating an immune system |
| 08/13/2009 | US20090202492 Adenovirus vaccine utilizing ikk as adjuvant |
| 08/13/2009 | US20090202484 Modulators of toll-like receptor 7 |
| 08/13/2009 | US20090202480 Macrocyclic serine protease inhibitors |
| 08/13/2009 | US20090202475 Compositions and methods for treatment of microbial disorders |
| 08/13/2009 | US20090202474 Expression of orphan gpr64 in inflammatory diseases |
| 08/13/2009 | US20090202471 Molecules with effects on cellular development and function |
| 08/13/2009 | US20090202441 Compositions and methods to prevent cancer with cupredoxins |
| 08/13/2009 | US20090202437 Therapeutic Use of Lpi, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory diseases |
| 08/13/2009 | US20090202431 Stem-like cells in bone sarcomas |
| 08/13/2009 | DE102008008558A1 Verfahren zur Gewinnung olfaktorischer Epithelzellen aus nicht-menschlichen embryonalen Stammzellen Process for the recovery of olfactory epithelial cells from non-human embryonic stem cells |
| 08/13/2009 | CA2715127A1 Siva3, its preparation and use |
| 08/13/2009 | CA2714512A1 Compositions and methods which modulate g-protein signaling for the treatment of asthma |
| 08/13/2009 | CA2714378A1 Treatment of chronic pain with zinc finger proteins |
| 08/13/2009 | CA2714370A1 Compounds that enhance atoh-1 expression |
| 08/13/2009 | CA2714297A1 Cell culture article and screening |
| 08/13/2009 | CA2714144A1 Maize leaf- and stalk-preferred promoter |
| 08/13/2009 | CA2714095A1 Cell culture method and screening method |
| 08/13/2009 | CA2713754A1 Synthetic surfaces for culturing cells in chemically defined media |
| 08/13/2009 | CA2712824A1 Siva 2 stabilization |
| 08/13/2009 | CA2712518A1 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 08/12/2009 | EP2088431A1 METHOD FOR ANALYSIS OF HEPATITIS B VIRUS s ANTIGEN |
| 08/12/2009 | EP2088207A1 Biomarkers and methods for identification of agents useful in the treatment of affective disorders |
| 08/12/2009 | EP2088203A1 Method for screening allergic disease-related molecule and cell line to be used in the method |
| 08/12/2009 | EP2088201A1 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
| 08/12/2009 | EP2088198A2 Transgenic systems for the manufacture of poly(3-hydroxy-butyrate-CO-3-hydroxyhexanoate) |
| 08/12/2009 | EP2088197A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 08/12/2009 | EP2088191A1 Induced blastocyst-like structures, methods of production and uses of the same |
| 08/12/2009 | EP2088190A1 Method for culture and passage of primate embryonic stem cell, and method for induction of differentiation of the embryonic stem cell |
| 08/12/2009 | EP2088188A1 Direct expression of peptides into culture media |
| 08/12/2009 | EP2088159A1 Antibody recognizing c-domain of midkine |
| 08/12/2009 | EP2087906A1 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 08/12/2009 | EP2087789A1 Fto-modified non-human mammal |
| 08/12/2009 | EP2087103A1 Cancerous disease modifying antibodies |
| 08/12/2009 | EP2087102A2 Enhancement of hybridoma fusion efficiencies through cell synchronization |
| 08/12/2009 | EP2087101A2 Endodermal progenitor cells |
| 08/12/2009 | EP2087100A1 Labeling of human epidermal stem cells |
| 08/12/2009 | EP2087099A1 Method for the isolation of pluripotent cells from a pre-implantation embryo in a culture medium free from animal serum |
| 08/12/2009 | EP2087098A2 Dedifferentiation of adult mammalian cardiomyocytes into cardiac stem cells |
| 08/12/2009 | EP2087097A2 Cells expressing alpha-synuclein and uses therefor |
| 08/12/2009 | EP2087003A2 Antibody with protein a selectivity |
| 08/12/2009 | EP2087002A2 Compositions and methods for binding sphingosine-1-phosphate |
| 08/12/2009 | EP2086579A2 Poultry vaccine, for necrotic enteritis, comprising a mutated clostridium perfringens alpha toxin antigen, and methods of producing the vaccine |
| 08/12/2009 | EP2086556A2 Mixed cell populations for tissue repair and separation technique for cell processing |
| 08/12/2009 | EP2086333A2 Isolated myeloid-like cell populations and methods of treatment therewith |
| 08/12/2009 | EP1981971A4 Adult stem cell-derived connective tissue progenitors for tissue engineering |
| 08/12/2009 | EP1909820A4 Modulation of granulosa cell apoptosis |
| 08/12/2009 | EP1906729A4 Plasma-depleted, non-red blood cell-depleted cord blood compositions and methods of use |
| 08/12/2009 | EP1784503A4 Urine markers for detection of bladder cancer |
| 08/12/2009 | EP1675579B1 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 08/12/2009 | EP1589814B1 Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications |
| 08/12/2009 | EP1514116B1 Oxaliplatin anti-resistance method |
| 08/12/2009 | EP1465912B9 Chimeric tnf ligands |
| 08/12/2009 | EP1456223B1 Rapidly maturing fluorescent proteins and methods for using the same |
| 08/12/2009 | EP1385882B9 Peptides and related molecules that bind to tall-1 |
| 08/12/2009 | EP1299414B1 Fluorescent proteins |
| 08/12/2009 | EP1259608B1 Modified fluorescent proteins |
| 08/12/2009 | EP1255813B1 Multipotent neural stem cells from mammalian skin and uses thereof |
| 08/12/2009 | EP1255780B1 Methods for generating human monoclonal antibodies |
| 08/12/2009 | EP1240514B1 Use of a biological sensor for sensing antibiotics |